TheScreener

RSS Feed Blog Podcast

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded. 

 

Regulatory Information

  • Regulatory Status: Under BaFin regulation

Free Trial

AC ENERGY CORP increases its risk exposure and slightly lowers to Neut...

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP ...

04/09/22 April 9, 2022 1 EN
Free Trial
12ZQ Vukile Property...

With a more favourable environment, VUKILE PROPERTY improves to Positi...

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potenti...

12ZQ VUKILE PROPERTY FUND LTD.
04/06/22 April 6, 2022 1 EN
Free Trial
17X2 Royal Bafokeng ...

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which s...

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date A...

17X2 ROYAL BAFOKENG PLATINUM
04/06/22 April 6, 2022 1 EN
Free Trial
100N Anglo American ...

An unfavourable environment weighs on ANGLO AMERICAN PLATINUM, which s...

The independent financial analyst theScreener just requalified the general evaluation of ANGLO AMERICAN PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date A...

100N ANGLO AMERICAN PLATINUM LIMITED
04/06/22 April 6, 2022 1 EN
Free Trial
BHVN Biohaven Pharma...

BIOHAVEN PHARMA sees an upgrade to Slightly Positive due to a better f...

The general evaluation of BIOHAVEN PHARMA (US), a company active in the Biotechnology industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date April 5, 2022, the closing price was USD...

BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
04/06/22 April 6, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch